See more : Mitsubishi Corporation (MSBHF) Income Statement Analysis – Financial Results
Complete financial analysis of AmerisourceBergen Corporation (ABC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AmerisourceBergen Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
- SPK Corporation (7466.T) Income Statement Analysis – Financial Results
- Yangzhou Yaxing Motor Coach Co., Ltd. (600213.SS) Income Statement Analysis – Financial Results
- Cemepe Investimentos S.A. (MAPT3.SA) Income Statement Analysis – Financial Results
- Ucommune International Ltd (UK) Income Statement Analysis – Financial Results
- Fire & Flower Holdings Corp. (FFLWF) Income Statement Analysis – Financial Results
AmerisourceBergen Corporation (ABC)
About AmerisourceBergen Corporation
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 262.17B | 238.59B | 213.99B | 189.89B | 179.59B | 167.94B | 153.14B | 146.85B | 135.96B | 119.57B | 87.96B | 79.49B | 80.22B | 77.95B | 71.76B | 70.19B | 66.07B | 61.20B | 54.58B | 53.18B | 49.66B | 45.23B | 16.19B | 11.65B | 9.81B | 8.67B | 7.82B | 5.55B | 4.67B | 4.30B |
Cost of Revenue | 253.21B | 230.29B | 207.05B | 184.70B | 174.45B | 163.33B | 148.60B | 142.58B | 132.43B | 116.59B | 85.45B | 76.82B | 77.68B | 75.60B | 69.66B | 68.14B | 63.75B | 58.97B | 52.60B | 51.00B | 47.41B | 43.21B | 15.49B | 11.12B | 9.33B | 8.25B | 7.43B | 5.25B | 4.40B | 4.06B |
Gross Profit | 8.96B | 8.30B | 6.94B | 5.19B | 5.14B | 4.61B | 4.55B | 4.27B | 3.53B | 2.98B | 2.51B | 2.67B | 2.54B | 2.36B | 2.10B | 2.05B | 2.33B | 2.23B | 1.98B | 2.18B | 2.25B | 2.02B | 700.12M | 520.89M | 475.60M | 423.10M | 389.30M | 304.90M | 268.80M | 243.30M |
Gross Profit Ratio | 3.42% | 3.48% | 3.24% | 2.73% | 2.86% | 2.75% | 2.97% | 2.91% | 2.60% | 2.49% | 2.85% | 3.36% | 3.17% | 3.02% | 2.93% | 2.92% | 3.52% | 3.65% | 3.63% | 4.10% | 4.53% | 4.48% | 4.32% | 4.47% | 4.85% | 4.88% | 4.98% | 5.49% | 5.76% | 5.66% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -58.48M | 888.84M | 958.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 2.66B | 2.46B | 2.13B | 2.09B | 1.92B | 1.59B | 1.33B | 1.23B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.32B | 324.14M | 334.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.31B | 4.85B | 3.59B | 2.77B | 2.66B | 2.46B | 2.13B | 2.09B | 1.92B | 1.59B | 1.33B | 1.23B | 1.20B | 1.16B | 1.13B | 1.12B | 1.41B | 1.40B | 1.26B | 1.21B | 1.29B | 1.22B | 408.76M | 303.04M | 281.80M | 254.90M | 255.40M | 195.40M | 160.90M | 150.70M |
Other Expenses | 1.31B | 693.90M | 505.17M | 391.06M | 462.41M | -25.47M | 2.73M | 5.05M | -13.60M | 4.36M | -44.00K | 5.83M | 0.00 | 0.00 | 1.43B | 1.43B | 1.51B | 1.48B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 6.62B | 5.54B | 4.10B | 3.16B | 3.13B | 2.93B | 2.53B | 2.46B | 2.16B | 1.77B | 1.50B | 1.37B | 1.33B | 1.25B | 1.20B | 1.21B | 1.50B | 1.48B | 1.34B | 1.29B | 1.36B | 1.28B | 427.63M | 320.46M | 301.70M | 271.50M | 269.70M | 207.00M | 171.00M | 165.40M |
Cost & Expenses | 259.83B | 235.83B | 211.15B | 187.86B | 177.58B | 166.25B | 151.12B | 145.03B | 134.59B | 118.36B | 86.95B | 78.19B | 79.01B | 76.85B | 70.86B | 69.35B | 65.25B | 60.45B | 53.94B | 52.29B | 48.77B | 44.49B | 15.92B | 11.44B | 9.63B | 8.52B | 7.70B | 5.45B | 4.57B | 4.22B |
Interest Income | 0.00 | 21.31M | 8.47M | 20.64M | 37.71M | 14.94M | 3.86M | 4.44M | 2.99M | 841.00K | 1.15M | 1.80M | 2.18M | 2.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 228.93M | 210.67M | 182.54M | 137.88M | 157.77M | 174.70M | 145.19M | 139.91M | 99.00M | 76.86M | 73.90M | 95.42M | 78.90M | 72.49M | 58.31M | 32.24M | 32.29M | 12.46M | 0.00 | 0.00 | 0.00 | 140.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 963.90M | 1.11B | 1.05B | 391.06M | 462.41M | 465.13M | 397.60M | 364.74M | 243.28M | 185.29M | 162.19M | 141.05M | 108.31M | 86.46M | 78.91M | 95.88M | 104.34M | 96.93M | 90.88M | 87.09M | 80.44M | 66.58M | 24.71M | 17.42M | 19.90M | 16.60M | 14.30M | 11.60M | 10.10M | 14.70M |
EBITDA | 3.37B | 3.47B | 3.41B | 2.43B | 2.49B | 2.08B | 2.42B | 2.19B | 1.60B | 1.40B | 1.17B | 1.45B | 1.32B | 1.19B | 974.43M | 950.52M | 931.83M | 841.25M | 843.99M | 994.88M | 967.77M | 833.49M | 307.59M | 216.73M | 208.70M | 194.90M | 133.90M | 109.50M | 107.90M | 272.40M |
EBITDA Ratio | 1.28% | 1.46% | 1.59% | 1.28% | 1.39% | 1.24% | 1.58% | 1.49% | 1.18% | 1.17% | 1.33% | 1.82% | 1.64% | 1.53% | 1.36% | 1.35% | 1.41% | 1.37% | 1.55% | 1.87% | 1.95% | 1.84% | 1.90% | 1.86% | 2.13% | 2.25% | 1.71% | 1.97% | 2.31% | 6.33% |
Operating Income | 2.34B | 2.37B | 2.35B | 2.04B | 2.03B | 1.44B | 1.11B | 1.53B | 417.37M | 778.88M | 898.40M | 1.25B | 1.20B | 1.10B | 883.75M | 827.86M | 820.34M | 748.71M | 636.95M | 890.43M | 883.11M | 718.43M | 259.38M | 200.43M | 173.90M | 151.60M | 119.60M | 97.90M | 97.80M | 77.90M |
Operating Income Ratio | 0.89% | 0.99% | 1.10% | 1.07% | 1.13% | 0.86% | 0.73% | 1.04% | 0.31% | 0.65% | 1.02% | 1.58% | 1.50% | 1.42% | 1.23% | 1.18% | 1.24% | 1.22% | 1.17% | 1.67% | 1.78% | 1.59% | 1.60% | 1.72% | 1.77% | 1.75% | 1.53% | 1.76% | 2.09% | 1.81% |
Total Other Income/Expenses | -179.90M | -183.32M | -132.34M | -7.33B | -1.06B | -266.26M | -92.46M | -134.86M | -143.22M | -105.46M | -73.94M | -89.60M | -72.10M | -75.87M | -59.68M | -66.52M | -35.29M | -8.08M | -168.12M | -130.06M | -156.98M | -146.38M | -56.54M | -40.73M | -54.60M | -68.80M | -41.60M | -35.90M | -52.30M | -242.50M |
Income Before Tax | 2.16B | 2.18B | 2.22B | -5.29B | 967.11M | 1.18B | 967.89M | 1.39B | 274.15M | 673.43M | 824.46M | 1.16B | 1.13B | 1.03B | 824.07M | 761.34M | 785.05M | 740.63M | 468.83M | 760.37M | 726.13M | 572.05M | 202.83M | 159.70M | 119.30M | 82.80M | 78.00M | 62.00M | 45.50M | -164.60M |
Income Before Tax Ratio | 0.82% | 0.91% | 1.04% | -2.79% | 0.54% | 0.70% | 0.63% | 0.95% | 0.20% | 0.56% | 0.94% | 1.46% | 1.41% | 1.32% | 1.15% | 1.08% | 1.19% | 1.21% | 0.86% | 1.43% | 1.46% | 1.26% | 1.25% | 1.37% | 1.22% | 0.96% | 1.00% | 1.12% | 0.97% | -3.83% |
Income Tax Expense | 428.26M | 516.52M | 677.25M | -1.89B | 112.97M | -438.47M | 553.40M | -37.02M | 409.04M | 389.40M | 331.02M | 454.95M | 424.02M | 391.02M | 312.22M | 292.27M | 291.28M | 272.62M | 176.90M | 291.98M | 284.90M | 227.11M | 77.73M | 60.69M | 48.40M | 32.30M | 30.60M | 19.30M | 17.30M | 7.80M |
Net Income | 1.75B | 1.70B | 1.54B | -3.40B | 855.37M | 1.66B | 414.48M | 1.43B | -134.89M | 276.48M | 433.71M | 718.99M | 706.62M | 636.75M | 503.40M | 250.56M | 469.17M | 467.71M | 319.20M | 468.39M | 441.23M | 344.94M | 125.10M | 99.01M | 67.50M | 50.50M | 45.40M | 35.50M | 10.20M | -207.70M |
Net Income Ratio | 0.67% | 0.71% | 0.72% | -1.79% | 0.48% | 0.99% | 0.27% | 0.97% | -0.10% | 0.23% | 0.49% | 0.90% | 0.88% | 0.82% | 0.70% | 0.36% | 0.71% | 0.76% | 0.58% | 0.88% | 0.89% | 0.76% | 0.77% | 0.85% | 0.69% | 0.58% | 0.58% | 0.64% | 0.22% | -4.83% |
EPS | 8.53 | 8.15 | 7.48 | -16.60 | 4.07 | 7.53 | 1.90 | 6.73 | -0.62 | 1.22 | 1.88 | 2.84 | 2.59 | 2.26 | 1.67 | 0.78 | 1.27 | 1.14 | 0.75 | 1.05 | 1.01 | 0.82 | 0.55 | 0.48 | 0.33 | 0.26 | 0.23 | 0.20 | 0.07 | -5.19 |
EPS Diluted | 8.53 | 8.04 | 7.39 | -16.60 | 4.04 | 7.53 | 1.87 | 6.32 | -0.62 | 1.17 | 1.84 | 2.80 | 2.54 | 2.22 | 1.66 | 0.77 | 1.25 | 1.13 | 0.74 | 0.99 | 0.95 | 0.77 | 0.50 | 0.48 | 0.33 | 0.25 | 0.23 | 0.19 | 0.07 | -5.19 |
Weighted Avg Shares Out | 204.59M | 208.47M | 205.92M | 204.78M | 210.17M | 217.87M | 218.38M | 212.21M | 217.79M | 227.37M | 231.07M | 252.91M | 272.47M | 282.26M | 300.57M | 321.28M | 370.36M | 410.02M | 425.26M | 447.35M | 435.38M | 419.74M | 228.74M | 206.21M | 202.79M | 190.71M | 198.35M | 182.05M | 145.71M | 40.00M |
Weighted Avg Shares Out (Dil) | 204.59M | 211.21M | 208.47M | 204.78M | 211.84M | 220.34M | 221.60M | 225.96M | 217.79M | 235.41M | 235.35M | 256.90M | 277.72M | 287.25M | 302.75M | 324.92M | 375.77M | 414.89M | 431.08M | 471.12M | 463.82M | 448.91M | 251.23M | 208.08M | 206.73M | 202.85M | 200.42M | 184.42M | 145.71M | 40.00M |
KGTV ABC 10News in San Diego recognized with National Press Foundation Award for 'Cost of Care'
Disney, DirecTV end blackout of ESPN, ABC as football season ramps up
First Horizon Announces Sponsorship of ABC's "Extreme Makeover: Home Edition"
Disney Deal With DirecTV Ends Blackout of ESPN, ABC
DirecTV-Disney Reach Deal That Ends ESPN, ABC Blackout
DirecTV rejects Disney offer to restore ABC for presidential debate
DirecTV and Disney's public squabble intensifies as Monday Night Football is set to air on ESPN and ABC
Disney Pulls ESPN, ABC and More Channels From DirecTV. Everything You Need to Know
DirecTV Users Lose Access to Disney Networks Including ESPN and ABC
Disney names veteran producer Almin Karamehmedovic president of ABC News
Source: https://incomestatements.info
Category: Stock Reports